NEWARK, Calif. (AP) — NEWARK, Calif. (AP) — Protagonist Therapeutics Inc. (PTGX) on Thursday reported a loss of $38.5 million in its second quarter.
The Newark, California-based company said it had a loss of 68 cents per share.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 65 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
